257 related articles for article (PubMed ID: 33777735)
61. Neurexophilin and PC-esterase domain family member 4 (NXPE4) and prostate androgen-regulated mucin-like protein 1 (PARM1) as prognostic biomarkers for colorectal cancer.
Liu YR; Hu Y; Zeng Y; Li ZX; Zhang HB; Deng JL; Wang G
J Cell Biochem; 2019 Oct; 120(10):18041-18052. PubMed ID: 31297877
[TBL] [Abstract][Full Text] [Related]
62. Identification of MFI2-AS1, a Novel Pivotal lncRNA for Prognosis of Stage III/IV Colorectal Cancer.
Luo R; Song J; Zhang W; Ran L
Dig Dis Sci; 2020 Dec; 65(12):3538-3550. PubMed ID: 31960204
[TBL] [Abstract][Full Text] [Related]
63. An Autophagy-Related Gene Signature Associated With Clinical Prognosis and Immune Microenvironment in Gliomas.
Xu Y; Li R; Li X; Dong N; Wu D; Hou L; Yin K; Zhao C
Front Oncol; 2020; 10():571189. PubMed ID: 33194668
[TBL] [Abstract][Full Text] [Related]
64. Prognostic value of immune scores in the microenvironment of colorectal cancer.
Yuan W; Cai W; Huang X; Peng S
Oncol Lett; 2020 Nov; 20(5):256. PubMed ID: 32994819
[TBL] [Abstract][Full Text] [Related]
65. Comprehensive analysis of differentially expressed lncRNAs as diagnostic and prognostic markers for colorectal cancer.
Zhang X; Zhang X; Shen L; Song L; Wu J; Cao G; Chen X; Zhu B
Exp Ther Med; 2019 Dec; 18(6):4481-4489. PubMed ID: 31772638
[TBL] [Abstract][Full Text] [Related]
66. Genome-wide expression profiling in colorectal cancer focusing on lncRNAs in the adenoma-carcinoma transition.
Kalmár A; Nagy ZB; Galamb O; Csabai I; Bodor A; Wichmann B; Valcz G; Barták BK; Tulassay Z; Igaz P; Molnár B
BMC Cancer; 2019 Nov; 19(1):1059. PubMed ID: 31694571
[TBL] [Abstract][Full Text] [Related]
67. Identification of the 3-lncRNA Signature as a Prognostic Biomarker for Colorectal Cancer.
Liu S; Cao Q; An G; Yan B; Lei L
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33302562
[TBL] [Abstract][Full Text] [Related]
68. A Correlation Study of Prognostic Risk Prediction for Colorectal Cancer Based on Autophagy Signature Genes.
Zhao H; Huang C; Luo Y; Yao X; Hu Y; Wang M; Chen X; Zeng J; Hu W; Wang J; Li R; Yao X
Front Oncol; 2021; 11():595099. PubMed ID: 34168974
[TBL] [Abstract][Full Text] [Related]
69. Identification of key lncRNAs in colorectal cancer progression based on associated protein-protein interaction analysis.
Zhu H; Yu J; Zhu H; Guo Y; Feng S
World J Surg Oncol; 2017 Aug; 15(1):153. PubMed ID: 28797257
[TBL] [Abstract][Full Text] [Related]
70. Identification of a Six-Immune-Related Long Non-coding RNA Signature for Predicting Survival and Immune Infiltrating Status in Breast Cancer.
Li Z; Li Y; Wang X; Yang Q
Front Genet; 2020; 11():680. PubMed ID: 32733537
[TBL] [Abstract][Full Text] [Related]
71. A Novel Framework to Predict Breast Cancer Prognosis Using Immune-Associated LncRNAs.
Huang Z; Xiao C; Zhang F; Zhou Z; Yu L; Ye C; Huang W; Li N
Front Genet; 2020; 11():634195. PubMed ID: 33584821
[No Abstract] [Full Text] [Related]
72. Identification of Five Glycolysis-Related Gene Signature and Risk Score Model for Colorectal Cancer.
Zhu J; Wang S; Bai H; Wang K; Hao J; Zhang J; Li J
Front Oncol; 2021; 11():588811. PubMed ID: 33747908
[TBL] [Abstract][Full Text] [Related]
73. Aberrant expression of long noncoding RNA SNHG15 correlates with liver metastasis and poor survival in colorectal cancer.
Huang L; Lin H; Kang L; Huang P; Huang J; Cai J; Xian Z; Zhu P; Huang M; Wang L; Xian CJ; Wang J; Dong J
J Cell Physiol; 2019 May; 234(5):7032-7039. PubMed ID: 30317592
[TBL] [Abstract][Full Text] [Related]
74. The Landscape of the Tumor-Infiltrating Immune Cell and Prognostic Nomogram in Colorectal Cancer.
Zhong J; Qin Y; Yu P; Xia W; Gu B; Qian X; Hu Y; Su W; Zhang Z
Front Genet; 2022; 13():891270. PubMed ID: 35646079
[TBL] [Abstract][Full Text] [Related]
75. HAMP as a Prognostic Biomarker for Colorectal Cancer Based on Tumor Microenvironment Analysis.
Wei FZ; Mei SW; Wang ZJ; Chen JN; Zhao FQ; Li J; Xiao TX; Zhao W; Ma YB; Yuan W; Liu Q
Front Oncol; 2022; 12():884474. PubMed ID: 35992796
[TBL] [Abstract][Full Text] [Related]
76. INHBA is a novel mediator regulating cellular senescence and immune evasion in colorectal cancer.
Chen S; Gong Y; Shen Y; Liu Y; Fu Y; Dai Y; Rehman AU; Tang L; Liu H
J Cancer; 2021; 12(19):5938-5949. PubMed ID: 34476008
[TBL] [Abstract][Full Text] [Related]
77. The Predictive Value of Neutrophil Extracellular Trap-Related Risk Score in Prognosis and Immune Microenvironment of Colorectal Cancer Patients.
Dong J; Zhao J; Wu Z; Liu J; Wang B; Qi X
Mol Biotechnol; 2024 Apr; ():. PubMed ID: 38580851
[TBL] [Abstract][Full Text] [Related]
78. PADI1 and Its Co-Expressed Gene Signature Unveil Colorectal Cancer Prognosis and Immunotherapy Efficacy.
Zhang YR; Zhang L; Li F; He JS; Xuan JF; Chen CC; Gong C; Pan YL
J Oncol; 2022; 2022():8394816. PubMed ID: 36471887
[TBL] [Abstract][Full Text] [Related]
79. Identification of
Liu J; Li Y; Gan Y; Xiao Q; Tian R; Shu G; Yin G
Front Cell Dev Biol; 2021; 9():671211. PubMed ID: 34178996
[TBL] [Abstract][Full Text] [Related]
80. AHCYL1 Is a Novel Biomarker for Predicting Prognosis and Immunotherapy Response in Colorectal Cancer.
Li X; Zhang M; Yu X; Xue M; Li X; Ma C; Jia W; Gao Q; Kang C
J Oncol; 2022; 2022():5054324. PubMed ID: 35578598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
